Streetbeat News

Revenues

GPN

Global Payments projects its FY24 adjusted EPS to be between $11.54 and $11.70, compared to the estimated $11.59. The company also forecasts adjusted revenue to range from $9.17 billion to $9.30 billion, versus the estimated $9.24 billion.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:59 am

ADP

ADP projects its FY24 consolidated revenue to grow by 6-7%, with adjusted EPS expected to increase by 10-12% and adjusted EBIT margin to expand by 60-70 basis points.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:58 am

EL

Estée Lauder Companies projects a decrease in FY24 net sales by 2-3% and organic net sales by 1-2%. Adjusted EPS is forecasted between $2.14 and $2.24, below the $2.25 estimate. Factors include currency headwinds, increased net interest expense, and potential disruptions in the Middle East. Adjusted diluted net earnings per share are expected to decrease by 33-36% on a constant currency basis.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:54 am

OSW

OneSpaWorld anticipates its Q2 total revenues to be between $216M and $221M, surpassing the estimated $215.746M.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:53 am

EL

Estée Lauder Companies (EL) provided a Q2 outlook with adjusted EPS of $0.18 to $0.28, below the $0.75 estimate, and expects revenue growth of 5% to 9%. The company anticipates a 1% headwind from foreign currency translation and projects organic net sales growth of 6% to 10%. Reported diluted EPS is forecasted between $.11 and $.22, with adjustments for restructuring and other charges. The outlook includes potential risks from business disruptions in Israel and the Middle East, impacting earnings by $.03 per share.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:52 am

AMD

QQQ

SPY

Wall Street is expected to open lower due to AMD's disappointing earnings, impacting the tech sector and broader market. However, the Federal Reserve's interest rate decision and Chairman Jerome Powell's press conference could influence the market's direction. Analysts see the April market pullback as a correction, setting the stage for a potential summer rally. Premarket trading saw SPDR S&P 500 ETF Trust and Invesco QQQ ETF decline. Economic data and bond yields have pressured stocks, with major indices ending lower in the previous session. Analysts anticipate Powell's guidance on rate outlook and expect a summer rally, considering it's an election year.

Portfolio Pulse from Shanthi Rexaline

May 01, 2024 | 10:44 am

PSN

Parsons has updated its fiscal year 2024 guidance, raising revenue expectations to $6.1B-$6.4B from the previous $5.8B-$6.0B, and adjusted EBITDA to $535M-$575M from $505M-$545M. This adjustment reflects strong Q1 performance and a positive outlook for the year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:41 am

CVS

CVS Health has revised its 2024 adjusted EPS guidance downwards to at least $7.00 from the previous forecast of at least $8.30, against a consensus of $8.27. This adjustment is due to the expectation that the utilization pressure experienced in the Health Care Benefits segment in the first quarter will continue throughout 2024.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:34 am

GTHX

G1 Therapeutics reaffirmed its 2024 net COSELA revenue guidance of $60M-$70M, expecting its cash runway to extend into Q3 of 2025. This outlook is based on anticipated acceleration of COSELA sales in the U.S.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:33 am

WLKP

Westlake Chemical (NYSE:WLKP) reported Q1 2024 earnings of $0.42 per share, missing the consensus estimate of $0.43 by 2.33%. Sales were $284.673M, exceeding estimates by 1.31% but marking a 7.48% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 10:32 am